Literature DB >> 33877675

MicroRNA-1269a promotes the occurrence and progression of osteosarcoma by inhibiting TGF-β1 expression.

S-N Yu1, Y-Y Miao, B T Zhang, Y-M Dai, L Liu, Z-L Gao, G-F Liu.   

Abstract

Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "MicroRNA-1269a promotes the occurrence and progression of osteosarcoma by inhibiting TGF-β1 expression, by S.-N. Yu, Y.-Y. Miao, B.T. Zhang, Y.-M. Dai, L. Liu, Z.-L. Gao, G.-F. Liu, published in Eur Rev Med Pharmacol Sci 2019; 23 (3): 972-981-DOI: 10.26355/eurrev_201902_16984-PMID: 30779063" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/16984.

Entities:  

Year:  2021        PMID: 33877675     DOI: 10.26355/eurrev_202104_25523

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  2 in total

Review 1.  BMP2 as a promising anticancer approach: functions and molecular mechanisms.

Authors:  Tong-Tong Li; Yong-Wei Lai; Xu Han; Xin Niu; Peng-Xia Zhang
Journal:  Invest New Drugs       Date:  2022-08-30       Impact factor: 3.651

2.  MicroRNA-1269 is downregulated in glioblastoma and its maturation is regulated by long non-coding RNA SLC16A1 Antisense RNA 1.

Authors:  Zhibin Jin; Heyang Li; Yinbo Long; Rong Liu; Xiaoguang Ni
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.